4//SEC Filing
Lalwani Narendra D. 4
Accession 0001179110-18-000392
CIK 0001434868other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 6:01 PM ET
Size
5.4 KB
Accession
0001179110-18-000392
Insider Transaction Report
Form 4
Lalwani Narendra D.
Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2018-01-02+36,000→ 36,000 totalExercise: $66.50Exp: 2028-01-02→ Common Stock (36,000 underlying)
Footnotes (1)
- [F1]The options vest over a four (4) year period in equal quarterly installments, the first of which will be on April 2, 2018.
Documents
Issuer
Esperion Therapeutics, Inc.
CIK 0001434868
Entity typeother
Related Parties
1- filerCIK 0001615012
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 6:01 PM ET
- Size
- 5.4 KB